Showing results (331-340 of 5,656) with videos related to
Sort By:
Pageof 566
Lupus|August 30, 2021
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center studyÜmmüşen Kaya Akca, Ezgi Deniz Batu, Ayşenur Pac Kısaarslan, et al.Lupus|August 30, 2021
Influenza A/Singapore (H3N2) component vaccine in systemic lupus erythematosus: A distinct pattern of immunogenicityFrancisco Fellipe Claudino Formiga, Clovis Artur Silva, Tatiana do Nascimento Pedrosa, et al.Lupus|July 20, 2016
Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidityC M Yelnik, G Urbanski, E Drumez, et al.Lupus|July 20, 2016
Encephalopathy with upper body hypertonia and myoclonus in patient with systemic lupus erythematosus and anti-CASPR2A Castro, J C Romeu, R Geraldes, et al.Lupus|July 20, 2016
Genetic selection pressure in TLR9 gene may enforce risk for SLE in Indian TamilsJ H Yusuf, D Kaliyaperumal, M Jayaraman, et al.Lupus|July 22, 2016
Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologistsS Shulman, J Wollman, S Brikman, et al.Lupus|October 27, 2019
Associations between paraoxonase-1 and systemic lupus erythematosusS-C Bae, Y H LeeLupus|August 20, 2016
Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunityM J Fritzler, E K L ChanLupus|April 9, 2020
Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activityShinya Hirahara, Yasuhiro Katsumata, Hidenaga Kawasumi, et al.Lupus|April 23, 2020
Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?Patricio M Aduriz-Lorenzo, Paula Aduriz-Llaneza, Javier Araiz-Iribarren, et al.Pageof 566